Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors

NCT04019470 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-02-07

No results posted yet for this study

Summary

To investigate the effect of radiotherapy on peripheral blood immune cell composition and function in pediatric malignant brain tumor patients.

Conditions

  • Brain Tumor, Pediatric

Sponsors & Collaborators

  • Capital Medical University

    lead OTHER

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2022-05-01
Completion
2022-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04019470 on ClinicalTrials.gov